Global Measles Vaccine Sales Market Report 2021

Global Measles Vaccine Sales Market Report 2021

Table of Contents
1 Measles Vaccine Market Overview
1.1 Measles Vaccine Product Scope
1.2 Measles Vaccine Segment by Type
1.2.1 Global Measles Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Measles Vaccine Segment by Application
1.3.1 Global Measles Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Children
1.3.3 Adults
1.4 Measles Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Measles Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Measles Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Measles Vaccine Price Trends (2016-2027)
2 Measles Vaccine Estimates and Forecasts by Region
2.1 Global Measles Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Measles Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Measles Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Measles Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Measles Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Measles Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Measles Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Measles Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Measles Vaccine Estimates and Projections (2016-2027)
2.4.3 China Measles Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Measles Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Measles Vaccine Estimates and Projections (2016-2027)
2.4.6 India Measles Vaccine Estimates and Projections (2016-2027)
3 Global Measles Vaccine Competition Landscape by Players
3.1 Global Top Measles Vaccine Players by Sales (2016-2021)
3.2 Global Top Measles Vaccine Players by Revenue (2016-2021)
3.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles Vaccine as of 2020)
3.4 Global Measles Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Measles Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Measles Vaccine Market Size by Type
4.1 Global Measles Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Measles Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Measles Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Measles Vaccine Price by Type (2016-2021)
4.2 Global Measles Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Measles Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Measles Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Measles Vaccine Price Forecast by Type (2022-2027)
5 Global Measles Vaccine Market Size by Application
5.1 Global Measles Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Measles Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Measles Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Measles Vaccine Price by Application (2016-2021)
5.2 Global Measles Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Measles Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Measles Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Measles Vaccine Price Forecast by Application (2022-2027)
6 North America Measles Vaccine Market Facts & Figures
6.1 North America Measles Vaccine Sales by Company
6.1.1 North America Measles Vaccine Sales by Company (2016-2021)
6.1.2 North America Measles Vaccine Revenue by Company (2016-2021)
6.2 North America Measles Vaccine Sales Breakdown by Type
6.2.1 North America Measles Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Measles Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Measles Vaccine Sales Breakdown by Application
6.3.1 North America Measles Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Measles Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Measles Vaccine Market Facts & Figures
7.1 Europe Measles Vaccine Sales by Company
7.1.1 Europe Measles Vaccine Sales by Company (2016-2021)
7.1.2 Europe Measles Vaccine Revenue by Company (2016-2021)
7.2 Europe Measles Vaccine Sales Breakdown by Type
7.2.1 Europe Measles Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Measles Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Measles Vaccine Sales Breakdown by Application
7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)
8 China Measles Vaccine Market Facts & Figures
8.1 China Measles Vaccine Sales by Company
8.1.1 China Measles Vaccine Sales by Company (2016-2021)
8.1.2 China Measles Vaccine Revenue by Company (2016-2021)
8.2 China Measles Vaccine Sales Breakdown by Type
8.2.1 China Measles Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Measles Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Measles Vaccine Sales Breakdown by Application
8.3.1 China 155 Sales Breakdown by Application (2016-2021)
8.3.2 China 155 Sales Breakdown by Application (2022-2027)
9 Japan Measles Vaccine Market Facts & Figures
9.1 Japan Measles Vaccine Sales by Company
9.1.1 Japan Measles Vaccine Sales by Company (2016-2021)
9.1.2 Japan Measles Vaccine Revenue by Company (2016-2021)
9.2 Japan Measles Vaccine Sales Breakdown by Type
9.2.1 Japan Measles Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Measles Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Measles Vaccine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Measles Vaccine Market Facts & Figures
10.1 Southeast Asia Measles Vaccine Sales by Company
10.1.1 Southeast Asia Measles Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Measles Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Measles Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Measles Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Measles Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Measles Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Measles Vaccine Market Facts & Figures
11.1 India Measles Vaccine Sales by Company
11.1.1 India Measles Vaccine Sales by Company (2016-2021)
11.1.2 India Measles Vaccine Revenue by Company (2016-2021)
11.2 India Measles Vaccine Sales Breakdown by Type
11.2.1 India Measles Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Measles Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Measles Vaccine Sales Breakdown by Application
11.3.1 India Measles Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Measles Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Measles Vaccine Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Measles Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi-Pasteur
12.2.1 Sanofi-Pasteur Corporation Information
12.2.2 Sanofi-Pasteur Business Overview
12.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
12.2.5 Sanofi-Pasteur Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Measles Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Measles Vaccine Products Offered
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Measles Vaccine Products Offered
12.5.5 Pfizer Recent Development
12.6 Serum Institute of India
12.6.1 Serum Institute of India Corporation Information
12.6.2 Serum Institute of India Business Overview
12.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Serum Institute of India Measles Vaccine Products Offered
12.6.5 Serum Institute of India Recent Development
12.7 China National Biotech Group
12.7.1 China National Biotech Group Corporation Information
12.7.2 China National Biotech Group Business Overview
12.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 China National Biotech Group Measles Vaccine Products Offered
12.7.5 China National Biotech Group Recent Development
12.8 Bavarian Nordic
12.8.1 Bavarian Nordic Corporation Information
12.8.2 Bavarian Nordic Business Overview
12.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bavarian Nordic Measles Vaccine Products Offered
12.8.5 Bavarian Nordic Recent Development
12.9 Emergent Biosolutions
12.9.1 Emergent Biosolutions Corporation Information
12.9.2 Emergent Biosolutions Business Overview
12.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Emergent Biosolutions Measles Vaccine Products Offered
12.9.5 Emergent Biosolutions Recent Development
12.10 Medimmune
12.10.1 Medimmune Corporation Information
12.10.2 Medimmune Business Overview
12.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Medimmune Measles Vaccine Products Offered
12.10.5 Medimmune Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Business Overview
12.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Measles Vaccine Products Offered
12.11.5 Johnson & Johnson Recent Development
12.12 CSL Limited
12.12.1 CSL Limited Corporation Information
12.12.2 CSL Limited Business Overview
12.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CSL Limited Measles Vaccine Products Offered
12.12.5 CSL Limited Recent Development
13 Measles Vaccine Manufacturing Cost Analysis
13.1 Measles Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Measles Vaccine
13.4 Measles Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Measles Vaccine Distributors List
14.3 Measles Vaccine Customers
15 Market Dynamics
15.1 Measles Vaccine Market Trends
15.2 Measles Vaccine Drivers
15.3 Measles Vaccine Market Challenges
15.4 Measles Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Measles Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Measles Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Measles Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Measles Vaccine Sales (K MT) by Region (2016-2021)
Table 5. Global Measles Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Measles Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Measles Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Measles Vaccine Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Measles Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Measles Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Measles Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Measles Vaccine Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Measles Vaccine Sales Share by Company (2016-2021)
Table 14. Global Measles Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Measles Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles Vaccine as of 2020)
Table 17. Global Measles Vaccine Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Measles Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Measles Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Measles Vaccine Sales (K MT) by Type (2016-2021)
Table 22. Global Measles Vaccine Sales Share by Type (2016-2021)
Table 23. Global Measles Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Measles Vaccine Price (USD/MT) by Type (2016-2021)
Table 25. Global Measles Vaccine Sales Share by Type (2022-2027)
Table 26. Global Measles Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Measles Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Measles Vaccine Price (USD/MT) by Type (2022-2027)
Table 29. Global Measles Vaccine Sales (K MT) by Application (2016-2021)
Table 30. Global Measles Vaccine Sales Share by Application (2016-2021)
Table 31. Global Measles Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Measles Vaccine Price (USD/MT) by Application (2016-2021)
Table 33. Global Measles Vaccine Sales (K MT) by Application (2022-2027)
Table 34. Global Measles Vaccine Sales Share by Application (2022-2027)
Table 35. Global Measles Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Measles Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Measles Vaccine Price (USD/MT) by Application (2022-2027)
Table 38. North America Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 39. North America Measles Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 43. North America Measles Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 45. North America Measles Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 47. North America Measles Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 49. North America Measles Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 51. Europe Measles Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 55. Europe Measles Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 57. Europe Measles Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 59. Europe Measles Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 61. Europe Measles Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 63. China Measles Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 67. China Measles Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 69. China Measles Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 71. China Measles Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 73. China Measles Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 75. Japan Measles Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 79. Japan Measles Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 81. Japan Measles Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 83. Japan Measles Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 85. Japan Measles Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Measles Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Measles Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Measles Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Measles Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Measles Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Measles Vaccine Sales (K MT) by Company (2016-2021)
Table 99. India Measles Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Measles Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Measles Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Measles Vaccine Sales by Type (2016-2021) & (K MT)
Table 103. India Measles Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Measles Vaccine Sales by Type (2022-2027) & (K MT)
Table 105. India Measles Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Measles Vaccine Sales by Application (2016-2021) & (K MT)
Table 107. India Measles Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Measles Vaccine Sales by Application (2022-2027) & (K MT)
Table 109. India Measles Vaccine Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. GSK Measles Vaccine Product
Table 114. GSK Recent Development
Table 115. Sanofi-Pasteur Corporation Information
Table 116. Sanofi-Pasteur Description and Business Overview
Table 117. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Sanofi-Pasteur Measles Vaccine Product
Table 119. Sanofi-Pasteur Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Merck Measles Vaccine Product
Table 124. Merck Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Novartis Measles Vaccine Product
Table 129. Novartis Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Pfizer Measles Vaccine Product
Table 134. Pfizer Recent Development
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Business Overview
Table 137. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Serum Institute of India Measles Vaccine Product
Table 139. Serum Institute of India Recent Development
Table 140. China National Biotech Group Corporation Information
Table 141. China National Biotech Group Description and Business Overview
Table 142. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. China National Biotech Group Measles Vaccine Product
Table 144. China National Biotech Group Recent Development
Table 145. Bavarian Nordic Corporation Information
Table 146. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Bavarian Nordic Description and Business Overview
Table 148. Bavarian Nordic Measles Vaccine Product
Table 149. Bavarian Nordic Recent Development
Table 150. Emergent Biosolutions Corporation Information
Table 151. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Emergent Biosolutions Description and Business Overview
Table 153. Emergent Biosolutions Measles Vaccine Product
Table 154. Emergent Biosolutions Recent Development
Table 155. Medimmune Corporation Information
Table 156. Medimmune Description and Business Overview
Table 157. Medimmune Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Medimmune Measles Vaccine Product
Table 159. Medimmune Recent Development
Table 160. Johnson & Johnson Corporation Information
Table 161. Johnson & Johnson Description and Business Overview
Table 162. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Johnson & Johnson Measles Vaccine Product
Table 164. Johnson & Johnson Recent Development
Table 165. CSL Limited Corporation Information
Table 166. CSL Limited Description and Business Overview
Table 167. CSL Limited Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. CSL Limited Measles Vaccine Product
Table 169. CSL Limited Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Measles Vaccine Distributors List
Table 173. Measles Vaccine Customers List
Table 174. Measles Vaccine Market Trends
Table 175. Measles Vaccine Market Drivers
Table 176. Measles Vaccine Market Challenges
Table 177. Measles Vaccine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles Vaccine Product Picture
Figure 2. Global Measles Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
Figure 5. Global Measles Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Children Examples
Figure 7. Adults Examples
Figure 8. Global Measles Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Measles Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Measles Vaccine Sales (K MT) Growth Rate (2016-2027)
Figure 11. Global Measles Vaccine Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 12. Global Measles Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Measles Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Measles Vaccine Sales (K MT) Growth Rate (2016-2027)
Figure 16. Europe Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Measles Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Measles Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Measles Vaccine Players Market Share by Revenue in Measles Vaccine: 2016 & 2020
Figure 27. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Measles Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Measles Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Measles Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Measles Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Measles Vaccine Sales Market Share by Type in 2020
Figure 33. North America Measles Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Measles Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Measles Vaccine Sales Market Share by Application in 2020
Figure 36. China Measles Vaccine Sales Market Share by Type in 2020
Figure 37. China Measles Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Measles Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Measles Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Measles Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Measles Vaccine Sales Market Share by Application in 2020
Figure 42. India Measles Vaccine Sales Market Share by Type in 2020
Figure 43. India Measles Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Measles Vaccine
Figure 46. Manufacturing Process Analysis of Measles Vaccine
Figure 47. Measles Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs